India’s rising diabetes burden has made the need for better, smarter treatments more urgent than ever. As a leading pharmaceutical manufacturer company, Akums Drugs & Pharmaceuticals Ltd. is playing an important role in improving how Type 2 diabetes is managed across the country. By bringing together strong research capabilities and advanced manufacturing, the company is helping make treatments more effective, accessible, and easier for patients to follow.
Advancing Diabetes Care through Innovative Formulations
Akums has been working hard towards the development of the next generation of anti-diabetic drugs, which go beyond the conventional limits of the current drugs. The idea is as simple as this: the treatment has to be made effective as well as easy to comply with.
Some of the major innovations are:
Triple Combination Therapy: This involves the development of a formulation that contains Sitagliptin, Pioglitazone, and Metformin in a single pill, making the treatment effective as well as reducing the pill burden on the patient.
Lobeglitazone tablets: This was one of the first launches of this particular molecule in India, which helps in the management of insulin resistance, thereby improving the metabolic profile of the patient.
Sustained release combinations: Vildagliptin SR + Metformin SR, which helps in the management of diabetes in the elderly population
Dual-action therapies: Dapagliflozin + Pioglitazone, which helps in the management of the challenges faced by patients with lifestyle-related diabetes
These efforts show how a pharmaceutical manufacturer company like Akums is doing more than just producing medicines. It is actively contributing to better, more practical treatment options. The emphasis on fixed-dose combinations also helps in improving patient compliance, an aspect that assumes importance when the condition needs to be controlled over the long term, as in the case of diabetes.
R&D and Manufacturing Excellence – Driving Progress
A significant portion of Akums’ success lies in their research and manufacturing abilities. The company has created an excellent platform for the development of sophisticated and potent anti-diabetic products.
Some of the major strengths of the company are:
- Cutting-edge R&D teams creating innovative delivery mechanisms and enhancing the way medication is absorbed by the body.
- Substantial expertise in the development of complex molecules and combination products
- Manufacturing facilities that are certified with GMP and have the capabilities of handling oral solids, liquid formulations, and sterile products
- Stringent quality checks and compliance with global regulations
As the best API manufacturer in India, Akums also provides consistent access to high-quality active pharmaceutical ingredients, which are critical components of diabetes management therapies. Akums’ capability to support API development as well as finished dosage forms gives them a significant advantage in this area.
Ensuring Quality, Compliance, and Global Standards
In pharmaceuticals, innovation only matters if it is backed by quality and compliance. This is an area where Akums places strong emphasis.
Leading regulatory agencies like the CDSCO, USFDA, UK MHRA and EU GMP regularly audit their facilities. They are also knowledgeable when it comes to the preparation of regulatory documents such as CTD, eCTD and DMF, which can facilitate quicker approvals and greater access to the market.
By maintaining their level of quality, Akums continues to build trust and grow in the global marketplace.
Focused on Patient-Centric Diabetes Management
At its core, Akums’ approach to Type 2 diabetes is centred on the patient. The goal is to make it easier, more effective, and simpler to take.
- Emphasis on once-daily regimens and simpler dosage forms
- Addressing underlying problems like insulin resistance
- Creating cost-effective solutions to make it more accessible
- Increasing patient compliance with combination therapies
By looking at both the medical and practical aspects of diabetes care, the company is helping patients manage their condition more effectively over the long term.
Driving the Future of Diabetes Care in India
As diabetes cases continue to rise in India, the need for scalable and affordable solutions is becoming increasingly important. Akums, as a trusted pharmaceutical manufacturer company and a recognised best API manufacturer in India, is playing a meaningful role in addressing this challenge.
With a strong focus on innovation, quality, and patient needs, the company is not just responding to the problem—it is helping shape the future of diabetes care in India and beyond.